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Abstract
Chromosome 17q11-q21 is a region of the genome likely to harbor susceptibility to autism 
(MIM[209850]) based on prior evidence of linkage to the disorder. This linkage is specific to 
multiplex pedigrees containing only male probands (MO) within the Autism Genetic Resource 
Exchange (AGRE). Previously, Stone et al.1 completed a high-density SNP association study of 
13.7Mb within this interval, but common variant association was not sufficient to account for the 
linkage signal. Here we extend this SNP-based association study to complete the coverage of the 2 
LOD support interval around the chromosome 17q linkage peak by testing the majority of 
common alleles in 284 MO trios.
CONCLUSIONS—Markers within an interval containing the gene CACNA1G were found to be 
associated with Autism Spectrum Disorder at a locally significant level (p = 1.9 × 10-5). While 
establishing CACNA1G as a novel candidate for autism, these alleles do not contribute sufficient 
genetic effect to explain the observed linkage, indicating there is substantial genetic heterogeneity 
despite the clear linkage signal. The region thus likely harbors a combination of multiple common 
and rare alleles contributing to the genetic risk. These data, along with previous studies of 
Chromosomes 5 and 7q3, suggest few if any major common risk alleles account for ASD risk 
under major linkage peaks in the AGRE sample. This provides important evidence for strategies to 
identify ASD genes, suggesting they should focus on identifying rare variants and common 
variants of small effect.
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INTRODUCTION
Autism (MIM[209850]) is a Pervasive Developmental Disorder (PDD) defined by 
impairment along three dimensions: language development, development of social 
behaviors, and the presence of stereotypic or rigid behavior. The diagnosis of “autistic 
disorder” encompasses a broad range of phenotypically diverse conditions with wide 
variation along the three dimensions of impairment, making autism a particularly 
heterogeneous disorder. “Autistic Disorder” is commonly grouped with Asperger’s 
Syndrome (MIM[608638]) and Pervasive Developmental Disorder Not Otherwise Specified 
(PDD-NOS) under the umbrella of Autism Spectrum Disorders (ASD).
Twin and family studies have provided strong evidence of heritability and suggest a high 
likelihood of genetic contribution for the susceptibility to autism. The monozygotic twin 
concordance rate is reported as high as 90% for ASD, while sibling concordance rates are 
approximately 10%2, 3. This indicates a strongly heritable yet genetically complex 
disorder4. The sibling relative risk is approximately 15-20 fold higher than the population 
frequency. The inheritance pattern of ASD is not consistent with a Mendelian disease model 
and can likely be better explained by the involvement of multiple interacting loci and 
environmental factors5. However, the degree of genetic complexity not been established.
The high prevalence6, 7 and strong heritability of ASD has encouraged multiple groups to 
complete whole-genome linkage studies8 searching for genomic regions likely harboring 
autism susceptibility alleles. One of the few genomic regions identified in an initial linkage 
studies and replicated at genome-wide significance is 17q11-q219, 10. The linkage signal 
was strengthened based on stratification of linkage data conditioned on the sex of affected 
siblings, which resulted in genome-wide significant linkage centered at 25-28 mega-bases 
(Mb) in multiplex families with exclusively male probands (male-only, or MO families) 
within the Autism Genetic Resource Exchange (AGRE)11. A replication study in a set of 
109 additional MO families from AGRE showed evidence of sex specific linkage extending 
over the same region, and fine mapping identified a region of linkage extending an 
additional 18 Mb from the end of the initial linkage peak9 centered at 61cM.
Previously, Stone et al.1 tested approximately half of the linkage interval on 17q11-q21 for 
association to common variants via high density single nucleotide polymorphism (SNP) 
genotyping. While the results demonstrated suggestive evidence of association of ASD to 
several interesting and novel candidates, the association signals were not sufficiently strong 
to account for the observed linkage signal within the AGRE MO families. Thus, we sought 
to cover the remaining likely linkage interval by testing common DNA variants 
comprehensively within the remaining 17q linkage region defined by fine mapping9, testing 
1975 SNPs at an average marker density of 6.3 kilo-bases (kb). This provided strong 
coverage of the majority of common haplotypes over the extended region of linkage, testing 
for ASD association within 295 genes in 284 independent trios from MO families in AGRE. 
We report the overall association analyses, which highlight CACNA1G as a novel candidate 
gene.
Strom et al. Page 2
Mol Psychiatry. Author manuscript; available in PMC 2011 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
MATERIALS AND METHODS
Genetic Material and Preparation
The Autism Genetic Resource Exchange (AGRE), an organization facilitating the collection 
of biomaterials and phenotypic information of families with autistic individuals, provided 
DNA samples for this study. AGRE has a standardized set of criteria for inclusion, which 
have been previously published12 and are available at www.agre.org. AGRE focuses on 
collecting genetic material from families with more than one individual diagnosed with 
Autism Spectrum Disorder (as defined by Liu et al.13).
For this study, both parents and one affected son were typed in 302 MO trios. After data 
cleaning, 296 remained (Supplemental Materials 1). Families containing individuals flagged 
for non-idiopathic autism because of other medical conditions such as Fragile-X Syndrome, 
birth trauma, and dysmorphic features, were not included in this study. Minor physical 
anomalies (MPA) as described by Ozgen et al.14 were not used as exclusion criteria, as this 
is a newly emerging area of phenotyping and has not yet been included in the AGRE cohort 
or other large genetic studies such as the Autism Genome Project (AGP)15. Every family 
meeting these criteria and having genetic materials available through AGRE at the time of 
assay design were included in this study.
Ethnicity was recorded via self-report, with 79% of those reporting identified as Caucasian. 
These reports are consistent with population structure analyses of the genotype data using 
the Structure software package16 (data not shown). Due to the family-based design and the 
out-bred nature of the population sampled (United States), ethnicity is not used as a factor in 
this study. This distribution will lead to an over-representation of Caucasian alleles overall, 
which will in turn increase the probability that discovered associated alleles will be specific 
to or enriched in the United States Caucasian population. The follow-up sample has a similar 
ethnicity distribution.
All subjects were diagnosed using the Autism Diagnosis Interview Revised (ADI-R)17. A 
subset of subjects were also diagnosed using the Autism Diagnostic Observation Schedule 
(ADOS)18. In total, 12 out of 296 individuals diagnosed as either autistic or broad spectrum 
on the ADI-R scored as ‘Not Spectrum or Autism’ on the ADOS (Table 1). These 
individuals were excluded from study due to their ambiguous phenotype. The 284 subjects 
surviving genotype cleaning and diagnostic criteria were included for all subsequent 
analysis.
Genomic DNA samples were obtained from the NIMH cell repository (Rutgers, Piscataway, 
NJ). Concentrations were determined using the Nanodrop (Wilmington, DE) instrument. 
The UCLA Internal Review Board (IRB) has approved all aspects of this study. A complete 
list of samples used in this study, along with gender, demographic, and diagnostic data are 
found in Supplementary Table 1.
SNP Selection
SNPs were selected using several criteria, including linkage disequilibrium (LD) data from 
the Hapmap project and ability to develop a working genotyping assay. To perform the SNP 
Strom et al. Page 3
Mol Psychiatry. Author manuscript; available in PMC 2011 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
selection, we first requested all possible dbSNP genotypes that will perform well in the 
Golden Gate assay per manufacturer’s guidelines (Illumina Inc., San Diego, CA). To 
maximize the amount of common variation tested while minimizing the number of markers 
typed, the software package Tagger19 was used to select a subset of these markers for 
genotyping such that the subset would cover the region of interest in the Hapmap (Build 
#21, July 2006) CEPH population with a minimum r2 value of 0.9. In total, 2042 SNPs were 
selected for genotyping in the region. Markers span 34.3Mb-47Mb on chromosome 17 
(17q12-q21.33). 1975 SNPs meet the following criteria: Hardy-Weinberg Equilibrium P-
Value ≥ 0.001, genotyping rate ≥ 85%, Mendelian Error Rate ≤ 1%.
SNP Genotyping
All SNPs were genotyped using a custom “BeadArray” DNA micro-array created by 
Illumina, Inc. (San Diego, CA) and the Golden Gate assay design. Genotyping was 
completed within the Southern California Genotyping Consortium, a local installation of the 
Illumina genotyping system at UCLA. Array assays were performed following standard 
protocols20.
Follow-Up Association
A formal replication set of sufficient size and equivalent gender stratification was not 
available to us. As a surrogate for formal replication, a follow-up association of 21 SNPs 
within CACNA1G was performed on 1046 affected trios from 556 AGRE pedigrees 
genotyped by the Children’s Hospital of Philadelphia (CHOP, AGRE Illumina 
HumanHap550 data). All pedigrees in this follow-up sample are independent of the initial 
sample. The male to female ratio of affected individuals in the follow-up sample is 2.11:1. 
All available samples meeting identical criteria to the initial association were tested for 
association. Siblings of the original sample were analyzed separately (262 individuals 
available from CHOP).
Association Analyses
Single SNPs were tested for association to ASD by performing a transmission 
disequilibrium test (TDT) using PLINK software.21 The PLINK TDT test computes a χ2 
statistic to assess the presence and significance of transmission biases. The ‘--perm’ option 
was used to calculate an empiric p-value for each SNP based on an adaptive permutation 
model. In this model, SNPs found to be non-associated after a low number of tests are 
dropped while SNPs with higher initial association are tested by up to millions of 
permutations.
To allow for haplotype analysis, groups of multiple markers were defined as haplotypes 
using the Four Gamete Test (FGT) implemented within Haploview22, identifying 340 block 
intervals. This test robustly assesses whether a recombination has occurred between two 
markers in a population. Haplotype-based TDT testing within Haploview was performed to 
assess the transmission bias of the blocks defined by the FGT.
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Copy Number Variant Detection
Signal intensity values in the form of Log R Ratios were used to identify regions of 
chromosome gain or loss, or copy number variations (CNV). Individual samples were 
normalized on both per sample and per marker basis and analyzed across five marker 
windows. Windows with mean score absolute values above three standard deviations were 
considered as either gain or loss, respectively. Detailed description of this method is found 
in Supplemental Materials 3.
RESULTS
Single SNP and Haplotype-based Association
To assess whether common variants in the chromosomal interval 17q11-q21 are associated 
with ASD, both single SNP and haplotype-based transmission disequilibrium tests were 
performed on 284 MO trios using 1975 markers. Full results from theses tests can be found 
in Figure 1 and Supplemental Table 2. Tagger software within Haploview 22 was used to 
assess the number of independent observations made by single SNP association. Using a 
linkage disequilibrium threshold of r2 ≥ 0.8, a total of 1452 single SNPs were sufficient to 
capture 100% of the alleles present in the sample. Thus, a stringent Bonferroni cutoff of 
0.05 / 1452 was used (corresponding to a -log10 P-Value of 4.463; P-Value = 0.000034435). 
Two SNPs, rs757415 (p=0.000019) and rs12603112 (p=0.000021), met criteria for multiple 
testing correction (Table 2). Both markers are located within intron 9 of voltage-dependent 
calcium channel alpha 1G (CACNA1G, Figure 2) and are in strong linkage disequilibrium 
(r2=0.99), indicating they tag a single allele contributing to increased ASD risk. While other 
alleles have nominally significant association, none is associated with ASD based on 
interval corrected significance levels.
Haplotype-based association yielded no locally significant blocks associated with ASD 
given the number of independent blocks assayed (Figure 3, Table 3). The block with the 
highest evidence of association (P-Value = 7.68 × 10-5, permutation P-Value = 0.068) was 
an over-transmission of a five-marker block including the two single SNPs identified as 
significantly associated with ASD (Figure 3). The FGT defined 14kb haplotype spans exons 
7-9 of the CACNA1G gene. Sixty-one affected individuals inheriting this haplotype from 
both parents drive this association, suggesting it may act as, or be tightly linked to, a 
recessive risk allele. Complete haplotype association results are found in Supplementary 
Table 3. A linkage disequilibrium plot for the SNPs tested within CACNA1G was plotted 
(Figure 4) and demonstrates the high degree of linkage disequilibrium (LD) between SNPs 
in the CACNA1G interval and the haplotypic structure of this genomic interval. Causal 
alleles underlying the association signal may reside anywhere within the gene.
Copy Number Variant Analysis
A comprehensive survey of copy number variation in the interval was performed to detect 
CNVs approximately 15kb or larger. Only one affected individual was identified as having 
region-wide significant copy number variant in the assayed interval using in-house 
developed analytical methods to analyze probe intensity data (Supplemental Materials 2, B. 
Merriman available on request). An approximately 28kb hemizygous loss was identified in 
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affected individual AU0920301, but not either parent (Supplemental Figure 1). The genomic 
interval spanned by this apparent de novo chromosome loss contains exon one of WFIKKN2 
and all of TOB1. Neither gene was identified via association or is a clear functional 
candidate. To date, no common CNVs in this interval have been reported23. While this 
CNV may contribute to ASD in this isolated case, it does not represent a general risk factor 
for autism. Further study is required to determine if this loss is functional or merely a benign 
event or statistical false positive. In total, no novel or previously identified CNVs ≥15kb in 
were detected in affected children within the interval. Shorter length variants may be 
present, but were not detectable given the density of markers assayed.
Follow-Up Association
A follow-up transmission bias test of 21 SNPs within CACNA1G in 1046 affected offspring 
trios yielded one marker exhibiting nominal association with ASD with an empiric P-value 
of 0.028 (Supplementary Table 4). The associated marker rs198547 is located within intron 
7 of CACNA1G. While these data do not represent replication of the same SNPs identified 
in the first stage, the nominal association of a SNP within CACNA1G in this sample in 
conjunction with the first stage analysis stresses the need for further study of variants in this 
gene. Further, we note that the replication set is not ideally powered to uncover risk alleles 
specifically related to the MO families, as the replication set is relatively devoid of male 
only affected sibling pairs which was the basis of the original linkage and now association 
finding. The marker rs12603112 is one of the two SNPs found to be associated with ASD at 
a locally significant level in the initial sample. A modest over-transmission of rs12603122 
was observed in affected siblings of the initial sample set (T:NT of 93:72), which is 
consistent with the original sample but not significant (p = 0.16).
DISCUSSION
Autism Spectrum Disorder (ASD) encompasses a diverse array of phenotypes. While highly 
heritable, ASD is a heterogeneous set of conditions as evidenced by the common distinct 
presentation of affected relatives2, 3, 12, 24-26. Due to this heterogeneity, few linkage 
regions have been confirmed by replication or validated by the discovery of risk alleles. 
Linkage within male-only multiplex pedigrees (MO) on chromosome 17q is one of the few 
genomic intervals replicated in ASD.
In this region of convincing a priori evidence for linkage, the common variant hypothesis 
was tested by performing association of 1975 markers spanning the 12.6Mb interval on 
chromosome 17q linked to autism spectrum disorder (ASD). With an average inter-marker 
distance of 6.3kb, 85% of known common haplotypes were detected, covering the complete 
2-LOD support interval. In this 12.6Mb region, two single SNPs in the interval were 
associated with ASD at a region-wide significant level, given conservative correction for the 
number of tests performed. These SNPs are adjacent and in strong LD (r2 0.99), and are 
located within intron 9 of the calcium channel gene CACNA1G. While this association 
could be considered relatively strong (odds ratio 95% confidence interval = 1.32-2.21, p = 
0.000019) for a complex disease such as ASD in a sample of this size, it does not fully 
explain the strength of the linkage signal. Multiple alleles with subtle effects or, more likely, 
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yet to be discovered rare variants in the 17q linkage region must also contribute to ASD risk 
in these families.
Since we have no a priori knowledge of how to identify families with a more homogeneous 
etiology, true risk variants are not distinct from false positives occurring due to the large 
number of tests required to rigorously assay a region of this size. Both the reduction of true 
association due to partial penetrance or low effect size, and the inflation of false association 
due to chance, impact heavily on such studies27, 28. Thus, the primary goal of this study 
was to reduce the entire region of linkage to a tenable number of nominally associated 
common polymorphisms such that genes can be highlighted for further study — including 
replication and re-sequencing — to better assess which nominal associations are 
representative of true risk alleles.
The region covered by this study (17q12-q21.33, 33.3Mb-47.0Mb, NCBI Build 36) contains 
295 known genes according to the RefSeq database29. Of these, only 8 genes are adjacent to 
single SNPs or haplotypes even nominally associated with ASD at ≤0.01 in this study 
(Supplemental Tables 2 and 3). The total number of single SNPs associated (17/1975, ∼1%) 
at this level is consistent with the number one would expect to find due to chance. The 
number of haplotypes associated (9/340, 2.5%) may be slightly elevated, but does not 
significantly differ from expectations. Thus, there does not appear to be an overall 
enrichment of associated SNPs or haplotypes with ASD in this interval, supporting the rare 
variant hypothesis.
Alleles of two SNPs (rs757415 and rs12603112) within CACNA1G were significantly over-
transmitted with P-Values ≤ 2.1×10-5. The calculated odds ratio of 1.30-2.21 (95% 
confidence interval) for these two markers is within the range of expectation for a minor 
effect allele, and is typical of common allele associations. Haplotype analysis identified a 5-
marker block of SNPs (containing these two markers) over-transmitted to probands (T:NT = 
154:92, p = 7.86×10-5). While the associated SNPs within the CACNA1G gene interval are 
intronic and do not have a predicted effect on gene expression or splicing, the associated 
haplotype spans a large portion of the gene, including several exons (Figure 2). One marker 
in a follow-up association sample is nominally associated with ASD. The follow-up set does 
not have an ideal gender stratification pattern, and the associated SNP is not in strong LD 
with the markers associated in the original study. Despite these limitations, finding nominal 
association in a separate sample of ASD patients supports CACNA1G as a positional 
candidate gene for the disorder. Conditioning the association on only affected male sibling 
pairs did not increase the strength of association (data not shown). While we are cautious of 
over interpreting this due to the small sample size, this may indicate the effects of 
CACNAIG genetic variation are not limited to MO families.
CACNA1G encodes a T-type voltage gated calcium channel30-32 which has been linked by 
a previous study to idiopathic generalized epilepsy32, indicating the gene modulates 
neuronal excitability and neural transmission. Varying reports have indicated a co-morbidity 
of epilepsy with autism at 5-38%. None of the probands in this study are known to have co-
morbidity with a seizure disorder, but it is reasonable to consider that uncharacterized 
mutations with different phenotypic effects in this gene could contribute to ASD. We 
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determined the relative frequency of the putative risk alleles in a subset of the AGRE sample 
for which EEG information was available. 208 of the genotyped affected individuals had 
EEG data available. There was no significant increase in the frequency of individuals with 
the associated allele (rs12603112) and EEG abnormality Supplemental Table 5). A larger 
sample size is required to assess the impact of CACNA1G haplotypes and abnormal brain 
activity or with more refined and complete phenotypic data.
Recent research has implicated calcium signaling and homeostasis as a possible molecular 
mechanism of autism33, 34, and several studies have linked mutations in other voltage-
gated calcium channels to syndromic35, 36 and non-syndromic autism37. CACNA1G is a 
strong functional candidate especially as a sexually dimorphic risk allele. There is known 
sexually dimorphic expressivity of this gene due to estrogen which may account for the 
association signal being detected in MO families38. Further, rare mutations in related 
calcium channels have been previously described33. Mutations in CACNA1C - a voltage 
gated calcium channel gene - cause Timothy Syndrome36, which can include autistic 
features. A CACNA1F mutation has been identified in a pedigree with night blindness, in 
which some of the male probands are also affected with autism35. Heterozygous mutations 
in CACNA1H were detected in 6 of 461 cases of non-syndromic autism37. Thus, by 
analogy and the work presented here, CACNA1G is a strong functional candidate and 
should be assessed for rare variants and spontaneous mutations.
These data support CACNA1G as a strong candidate gene for ASD in at least a subset of 
cases. While the results of a follow-up association analysis in 1046 affected offspring trios 
(556 new independent pedigrees) supports CACNA1G as an ASD candidate gene, 
replication in a large gender matched sample is required to assess the veracity of the 
association. Re-sequencing to detect potential rare variants in this gene is warranted. Within 
the analysis of the remainder of the interval, genes warranting further replication in the 
tested interval, identified as containing nominally associated SNPs or haplotypes include: 
CACNB1, DUSP3, KIF18B, SKAP1, and CRHR1. Of these, three (CACNB1, DUSP3, and 
CRHR1) have known transcriptional patterns or biological activities suggesting they play a 
role in brain function, and are biological and positional candidates for ASD also meriting 
further study to assess potential risk alleles. Copy Number Variant detection identified a 
single individual with an apparent spontaneous hemizygous loss spanning approximately 
28kb. Two genes, TOB1 and WFIKKN2, are potentially disrupted by this event. However, 
the implications of such a loss are not clear given the isolated nature of the event and lack of 
association in the interval. No structural variants in CACNA1G were detected.
This study has identified the calcium channel subunit gene CACNA1G as a novel candidate 
gene for Autism Spectrum Disorder. Further investigation, including replication to confirm 
common variants and DNA re-sequencing to identify rare variants, is required to establish 
the role CACNA1G may play in the etiology of the disorder. Combined with our previous 
studies1, the majority of common variants in the replicated ASD linkage region on 
chromosome 17q have now been tested for association. These findings demonstrate that 
while multiple loci in the interval may contribute to the disorder, the sum of the effects of 
individual common variants alone cannot explain the strength and replication of linkage. 
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Rather, gene-gene interactions, gene-environment interactions, rare variants, or other 
mechanisms not yet implicated must contribute to the etiology of this complex disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Single marker Association Results
Individual SNP transmission biases from 284 Male-Only autism trios are plotted as -Log10 
of the empiric P-Value versus genomic position in mega-bases (Mb). Local significance 
threshold is represented by a black dotted line. Two markers (filled triangles) out of 1975 
markers tested are associated at a locally significant level, adjacent SNPs within 
CACNA1G.
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Figure 2. Single marker Association Results for CACNA1G
Individual SNP transmission biases from 284 Male-Only autism trios of markers within the 
genetic interval containing the CACNA1G gene are plotted as -Log10 of the empiric P-
Value versus genomic position in mega-bases (Mb). Local significance threshold is 
represented by a black dotted line. Two markers (rs757415 and rs12603112; filled triangles) 
are associated at a locally significant level. A gene diagram representing exons (blue 
rectangles), introns (blue lines), and direction of transcription (blue arrowheads) is included 
for reference.
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Figure 3. Haplotype Association Results
Haplotype transmission biases from 284 Male-Only autism trios are plotted as -Log10 of the 
P-Value versus genomic position in mega-bases (Mb). For each block locus, only the block 
with the most significant P-Value is plotted. Nominal local significance threshold (P-Value 
≤ 0.001) is represented by a black dotted line. One haplotype (circled) are associated at this 
nominal level. This block contains the two individual SNPs found to be associated at a 
locally significant level.
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Figure 4. Linkage Disequilibrium Status of SNPs within CACNA1G
Haplotypes estimated from 284 Male-Only autism trios using the Four Gamete Test (FGT) 
are plotted as a function of D‘. Approximate location of CANCA1G in relation to the 
markers is represented by the UCSC Genome Browser track at the top of the figure. Block 3 
(highlighted in blue) is the block most associated with Autism Spectrum Disorder in this 
study (P-Value < 7.68 × 10-5).
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Table 4
Follow-up Association Results
Single SNP Transmission Disequilibrium tests for the marker within CACNA1G in a follow-up sample of 
1046 affected individuals from 556 independent trios with an Empiric P-Value ≤ 0.05 is shown. Marker 
identifier (‘SNP’), genomic position of Chromosome 17 (‘Position’), Transmitted versus Non-Transmitted 
count (‘T:NT’), odds ratio, and empiric p-value corresponding to each associated marker are listed.
SNP Position T:NT Odds Ratio Empiric P-Value
rs198547 46006810 138:176 0.7841 0.02804
Mol Psychiatry. Author manuscript; available in PMC 2011 April 01.
